Ortho Clinical Diagnostics Holdings plc

:OCDX

16.49

+0.42 (+2.61%)

Market Cap (Intraday)	3.96B
Current PE	N/A
Forward PE	30.54
2yr Forward PE	23.9

See more stats

Estimates Current Quarter

Revenue	$433.57 Million
Adjusted EPS	$0.10

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Ortho Clinical Diagnostics Holdings Plc Stock, :OCDX

1001 Route 202, Raritan, New Jersey 08869

United States of America

Phone: +1.908.218.8000

Number of Employees: 4500

http://www.orthoclinicaldiagnostics.com

Description

Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS� XT 3400 Chemistry System, VITROS� 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company is headquartered in Raritan, NJ.